CommodityGraph
Shadow fleetSanctions checkTradersSanctionsChangesMethodology
CompanyCHE-386.841.064

Tanai Therapeutics GmbH — Basel

  • No officers on record
  • 1 related entity
  • 1 jurisdiction
  • No exact current sanctions matches found
  • 2 changes detected in the last 90 days

Company information

Click a badge to inspect the source
Registered name
Tanai Therapeutics GmbH
Source
Verified: copied from a structured field of an authoritative source
Source
SHAB/FOSC – Swiss Official Gazette of Commerce
Retrieved
2026-11-06
Source date
2026-11-06
Extractor
shab-xml-v1
Raw evidence
Tanai Therapeutics GmbH (Tanai Therapeutics Sàrl) (Tanai Therapeutics LLC), in Basel, CHE-386.841.064, c/o VISCHER AG, Aeschenvorstadt 4, 4051 Basel, Gesellschaft mit beschränkter Haftung (Neueintragung). Statutendatum: 19.10.2026. Zweck: Die Gesellschaft bezweckt die Forschung, Entwicklung und Komm
Swiss UID
CHE-386.841.064
LEI
Not available
Legal form
Limited liability company (Sàrl/GmbH)
Register status
Active
Registered seat
Basel, Basel-Stadt
Source
Verified: copied from a structured field of an authoritative source
Source
SHAB/FOSC – Swiss Official Gazette of Commerce
Retrieved
2026-11-06
Source date
2026-11-06
Extractor
shab-xml-v1
Raw evidence
Tanai Therapeutics GmbH (Tanai Therapeutics Sàrl) (Tanai Therapeutics LLC), in Basel, CHE-386.841.064, c/o VISCHER AG, Aeschenvorstadt 4, 4051 Basel, Gesellschaft mit beschränkter Haftung (Neueintragung). Statutendatum: 19.10.2026. Zweck: Die Gesellschaft bezweckt die Forschung, Entwicklung und Komm
Address
Basel
Source
Verified: copied from a structured field of an authoritative source
Source
SHAB/FOSC – Swiss Official Gazette of Commerce
Retrieved
2026-11-06
Source date
2026-11-06
Extractor
shab-xml-v1
Raw evidence
{"line1":"c/o VISCHER AG","street":"Aeschenvorstadt","houseNumber":"4","zip":"4051","town":"Basel"}
Share capital
CHF 25,000
Source
Verified: copied from a structured field of an authoritative source
Source
SHAB/FOSC – Swiss Official Gazette of Commerce
Retrieved
2026-11-06
Source date
2026-11-06
Extractor
shab-xml-v1
Raw evidence
capital nominal 25000
Founded / registered
2026-11-06
Statutory purpose
Die Gesellschaft bezweckt die Forschung, Entwicklung und Kommerzialisierung von pharmazeutischen Produkten und Technologien. Die Gesellschaft kann alle Geschäfte tätigen und Massnahmen ergreifen, die geeignet sind, den Gesellschaftszweck direkt oder indirekt zu fördern, wie beispielsweise im In- und Ausland Unternehmungen aller Art, Grundstücke und Immaterialgüterrechte erwerben, verwalten, nutzen, belasten und veräussern, Zweigniederlassungen und Agenturen begründen sowie Kredite gewähren, Kapitalien verwalten und Garantien zugunsten von verbundenen Gesellschaften stellen.

Commodities & activity

classified from the registered purpose

No commodity activity identified in the registered purpose.

Officers & directors (0 current)

Known from official Swiss Official Gazette of Commerce (SHAB/FOSC) notices since its digital archive began (~2019). Officers registered earlier and never mentioned in a later notice may be missing.

No officer appointments found in gazette notices for this company.

Related entities (1)

Auditor (1)

  • Tria Revisions AGCompany · CH · since 2026-11-06
    Derived 80%
    Derived by a deterministic rule from source data
    Source
    SHAB/FOSC – Swiss Official Gazette of Commerce
    Retrieved
    2026-11-06
    Source date
    2026-11-06
    Confidence
    80%
    Extractor
    shab-rules-prose-v1
    Raw evidence
    Tria Revisions AG (CHE-101.644.241) [ CH-020.3.006.116-1], in Cham, Revisionsstelle.

Sanctions screening

No exact current sanctions matches found across OFAC, UK, EU, UN and SECO lists (screened 2026-11-15). Screening compares identifiers (UID, LEI, registration numbers) and exact normalised names with the same country.

Screening is automated and informational. A listed entry with a similar or identical name is not necessarily the same legal entity. This is not a legal or compliance determination.

Timeline of detected changes (2)

  1. Auditor changed
    Derived 90%
    Derived by a deterministic rule from source data
    Source
    SHAB/FOSC – Swiss Official Gazette of Commerce
    Retrieved
    2026-11-06
    Source date
    2026-11-06
    Confidence
    90%
    Raw evidence
    Tria Revisions AG (CHE-101.644.241) [ CH-020.3.006.116-1], in Cham, Revisionsstelle.

    Auditor changed

  2. Registered in commercial register
    Derived 90%
    Derived by a deterministic rule from source data
    Source
    SHAB/FOSC – Swiss Official Gazette of Commerce
    Retrieved
    2026-11-06
    Source date
    2026-11-06
    Confidence
    90%
    Raw evidence
    Tanai Therapeutics GmbH (Tanai Therapeutics Sàrl) (Tanai Therapeutics LLC), in Basel, CHE-386.841.064, c/o VISCHER AG, Aeschenvorstadt 4, 4051 Basel, Gesellschaft mit beschränkter Haftung (Neueintragung). Statutendatum: 19.10.2026. Zweck: Die Gesellschaft bezweckt die Forschung, Entwicklung und Kommerzialisierung von pharmazeutischen Produkten und Technologien. Die Gesellschaft kann alle Geschäfte

    New entry in the commercial register

Recent news

No recent news articles matched.

Headlines link to the original publisher; we store only title, outlet and date (via GDELT).

Compiled automatically from official public sources. Name similarity is not identity; nothing here is a legal determination or allegation of wrongdoing. Verify against the linked official source before relying on any information.